Conceptio
›
multiple-myeloma
Topic
multiple-myeloma
Knowledge-graph topic
· documents ABOUT multiple-myeloma across the archive
675
Documents about multiple-myeloma
Documents about multiple-myeloma
Study of ISB 2001 in Relapsed/Refractory Multiple Myeloma (TRIgnite-1)
#900743
ClinicalTrials.gov
"WB-DCE-MRI" in Multiple Myeloma as an Independent Prognostic Factor for Disease-free Survival
#907597
ClinicalTrials.gov
A Study of KQ-2003 CAR-T Cell Therapy for Patients With Relapsed or Refractory Multiple Myeloma
#913522
ClinicalTrials.gov
Escalating Doses of Thalidomide in Conjunction With Bortezomib and HIgh Dose Melphalan for BSCT
#914411
ClinicalTrials.gov
mRNA-2736 for Participants With Relapsed or Refractory Multiple Myeloma (RRMM)
#915391
ClinicalTrials.gov
Total Marrow Irradiation With High Dose Melphalan Prior to Autologous Transplant for Multiple Myeloma
#979107
ClinicalTrials.gov
Japanese Phase 1 Study to Evaluate Tolerated Dose, Safety, and Efficacy of Pomalidomide in Patients With Refractory or Relapsed and Refractory Multiple Myeloma
#981432
ClinicalTrials.gov
Lenalidomide, Adriamycin, Dexamethasone (RAD) Versus Lenalidomide, Bortezomib, Dexamethasone (VRD) for Induction in Newly Diagnosed Multiple Myeloma Followed by Response-adapted Consolidation and Lenalidomide Maintenance
#826506
ClinicalTrials.gov
Bone Marrow Transplant in Treating Patients With Hematologic Cancers
#980940
ClinicalTrials.gov
Ibrutinib, Lenalidomide, and Dexamethasone in Treating Patients With Multiple Myeloma Ineligible for Transplant
#837465
ClinicalTrials.gov
Patient-Centered Education Through A Massive Open Online Course (MOOC) for Patients With Multiple Myeloma and Caregivers: Descriptive Study of Knowledge Gains by French Association of Patients With Multiple Myeloma (AF3M) and French-Speaking Myeloma Intergroup (IFM)
#120678
HAL (France)
Umbilical Cord Blood and Placental Blood Transplantation in Treating Patients With Hematologic Cancer or Aplastic Anemia
#855872
ClinicalTrials.gov
Maintenance Belantamab Mafodotin (Blenrep®) After B-cell Maturation Antigen-Directed Chimeric Antigen Receptor T-cell Therapy in Patients With Relapsed and/or Refractory Multiple Myeloma
#872216
ClinicalTrials.gov
Multicenter Open Label Phase 3 Study of Isatuximab Plus Lenalidomide and Dexamethasone With/Without Bortezomib in the Treatment of Newly Diagnosed Non Frail Transplant Ineligible Multiple Myeloma Elderly Patients (≥ 65; < 80 Years).
#444885
ClinicalTrials.gov
Daratumumab, Ixazomib, & Dexamethasone or Daratumumab, Bortezomib, & Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma
#442095
ClinicalTrials.gov
Contribution of Rotational Thromboelastometry (ROTEM) research parameters for the evaluation of hypercoagulability in patients with Multiple Myeloma. A pilot study
#294817
IRIS
Stem Cell Transplant, Chemotherapy, and Biological Therapy in Treating Patients With High-Risk or Refractory Multiple Myeloma
#377284
ClinicalTrials.gov
Superiority of VCD Versus CTD in Patients With Newly Diagnose Multiple Myeloma Eligible for Transplantation
#810347
ClinicalTrials.gov
Standard Care Alone or With Acupuncture for CIPN in Breast Cancer and Multiple Myeloma
#825358
ClinicalTrials.gov
Ph 1b Study to Evaluate GSK2110183 in Combination With Bortezomib and Dexamethasone in Subjects With Multiple Myeloma
#826202
ClinicalTrials.gov
Comparison of Zometa Retention and Effect in Multiple Myeloma and Breast Cancer
#829944
ClinicalTrials.gov
A Dietary Study for People With Multiple Myeloma
#846926
ClinicalTrials.gov
A Study to Determine the Effect and Safety of an Oral Janus Kinase 2 (JAK2)-Inhibitor (Ruxolitinib; INBC018424) in Patients With Multiple Myeloma
#863996
ClinicalTrials.gov
Pilot Study of Blinatumomab in Combination With Salvage Autologous Stem Cell Transplantation for Patients With Refractory Multiple Myeloma
#864267
ClinicalTrials.gov
Safety and Efficacy of ALLO-715 BCMA Allogenic CAR T Cells in in Adults With Relapsed or Refractory Multiple Myeloma (UNIVERSAL)
#865765
ClinicalTrials.gov
Safety and Efficacy of Anti-BCMA/GPRC5D CAR-T Cell Therapy in Treating Relapsed and Refractory Multiple Myeloma(rr/MM)
#875737
ClinicalTrials.gov
A Phase 2 Trial of MP0250 Plus Bortezomib + Dexamethasone in Patients With Multiple Myeloma
#886883
ClinicalTrials.gov
A Phase II Trial Using Meloxicam Plus Filgrastim in Patients With Multiple Myeloma and Non-Hodgkin's Lymphoma
#889053
ClinicalTrials.gov
Feasibility Study of an ePRO Monitoring for Patients With Multiple Myeloma and Development of Item Lists
#889709
ClinicalTrials.gov
BCMA-CS1 Compound CAR (cCAR) T Cells for Relapsed/Refractory Multiple Myeloma
#893354
ClinicalTrials.gov
VTD Followed By MPT Maintenance As a First Line Treatment For The Patients With MM Who Are Non-Transplant Candidates
#904097
ClinicalTrials.gov
Iberdomide-dexamethasone Alone or in Combination With Standard MM Treatment Regimens in Transplant Ineligible Newly Diagnosed Patients.
#917644
ClinicalTrials.gov
THAL-DEX Incorporated Into Double PBSC Autotransplantation for Untreated Multiple Myeloma (MM)
#917996
ClinicalTrials.gov
1454GCC: Anti-PD-1 (MK-3475) and IMiD (Pomalidomide) Combination Immunotherapy in Relapsed/Refractory Multiple Myeloma
#918426
ClinicalTrials.gov
Aspirin or Rivaroxaban Thromboprophylaxis for Patients With Multiple Myeloma
#981075
ClinicalTrials.gov
A Phase 1b/2, Dose-Escalation Study of Elotuzumab (Humanized Anti-CS1 Monoclonal IgG1 Antibody) in Relapsed Multiple Myeloma
#993863
ClinicalTrials.gov
Universal CAR-T Cells (REVO-UWD-00B) for Refractory and Relapsed Multiple Myeloma
#854782
ClinicalTrials.gov
Total-Body Irradiation, Fludarabine, and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer
#848438
ClinicalTrials.gov
Music Therapy to Ease Pain and Emotional Distress in Patients With Hematologic Cancer Who Are Undergoing High-Dose Therapy and Stem Cell Transplantation
#915634
ClinicalTrials.gov
Prognostic and biological implications of genetic abnormalities in multiple myeloma undergoing autologous stem cell transplantation: t(4;14) is the most relevant adverse prognostic factor, whereas RB deletion as a unique abnormality is not associated with adverse prognosis
#294461
Gestión del Repositorio Documental de la Universidad de Salamanca
Leflunomide, Pomalidomide, and Dexamethasone for the Treatment of Relapsed or Refractory Multiple Myeloma
#230395
ClinicalTrials.gov
Study Evaluating Venetoclax in Subjects With Hematological Malignancies
#805982
ClinicalTrials.gov
INfections in Patients Treated With CAR-T
#839746
ClinicalTrials.gov
A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS)
#918366
ClinicalTrials.gov
Daratumumab as Maintenance After Peripheral Blood Stem Cell Transplantation From HLA-identical or Haploidentical Family Donor in the Treatment of Refractory or Relapsed Multiple Myeloma: a Phase 2 Trial
#874089
ClinicalTrials.gov
Lymphodepleting Total Body Irradiation (TBI) Plus Cyclophosphamide Prior to Ciltacabtagene Autoleucel (Carvykti; Cilta-cel) for Multiple Myeloma (MM) Patients With Impaired Renal Function
#136311
ClinicalTrials.gov
Open-label Study, to Evaluate the Safety and Tolerability of Zoledronic Acid in Patients With Bone Lesions Secondary to Multiple Myeloma.
#828365
ClinicalTrials.gov
A Safety Study of Lenalidomide in Previously Untreated Adult Multiple Myeloma Patients Who Are Not Eligible for Transplant
#852566
ClinicalTrials.gov
Bioengineered Allogeneic Immune Cells (AlloStim) Not Requiring HLA Donor Match for Blood Cancers
#853532
ClinicalTrials.gov
Urinary Protein/Creatinine Ratio in a Single Urine Sample Versus 24-hour Proteinuria in Patients With Multiple Myeloma
#857673
ClinicalTrials.gov
← Previous
Page 9 of 20
Next →
Topic record
· derived from the Conceptio knowledge graph (shared subject terms across the corpus)
Conceptio Open Knowledge Archive — topic hubs link to canonical document pages with full provenance.